Comments to China Food and Drug Administration (CFDA) on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition)

2017-02-20 | Beijing

The European Chamber submitted collated comments to CFDA on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition). The comments underlined the following aspects:

  1. The lack of consideration on the economic and legal significance on brands;
  2. The lack of legitimate force to regulate by citing examples;
  3. The lack of consideration on the differences of pharmaceutical products and the infant formula as the Fast Moving Consumer Goods.